Ftse Mib
38.361,84
0,36%
DAX
22.747,06
0,62%
S&P 500
5.614,56
-2,70%
NASDAQ
17.468,32
-4,00%
Bitcoin
81.685,83
4,09%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Aditxt Inc (ADTX) Aditxt Inc (ADTX) Notizie

Aditxt Inc

ADTX
0,0538
-0,0022 (-3,93%)
Pre Mercato
Ultimo aggiornamento: 11:24:55
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
24/2/202515:17EDGAR2Form 8-K - Current report
21/2/202514:15BWAditxt Subsidiary Pearsanta Engages Dominari Securities for..
14/2/202523:06GLOBEAppili Therapeutics Reports Financial and Operational..
13/2/202514:15BWAditxt to Host Fireside Chat on Friday, February 21st at..
27/1/202523:10EDGAR2Form DEF 14A - Other definitive proxy statements
17/1/202522:15EDGAR2Form PRER14A - Preliminary Proxy Soliciting materials
13/1/202514:15EDGAR2Form 8-K - Current report
13/1/202514:15BWAditxt’s Board of Directors Unanimously Approve Positioning..
12/12/202422:15EDGAR2Form 8-K - Current report
12/12/202414:15BWAditxt's Subsidiary Adimune Successfully Completes..
06/12/202422:15EDGAR2Form PRE 14A - Other preliminary proxy statements
21/11/202422:15EDGAR2Form 8-K/A - Current report: [Amend]
21/11/202422:15EDGAR2Form 8-K/A - Current report: [Amend]
19/11/202422:15EDGAR2Form 8-K - Current report
19/11/202413:17GLOBEAppili Therapeutics Announces Receipt of Final Court Order..
18/11/202423:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
15/11/202412:07EDGAR2Form NT 10-Q - Notification of inability to timely file Form..
14/11/202422:36PRNUSEvofem Biosciences Announces Financial Results for the Third..
14/11/202413:15GLOBEAppili Therapeutics Reports Financial and Operational..
08/11/202414:30BWAditxt Provides Update on Equity Line of Credit, ATM Usage,..
07/11/202414:30BWAditxt’s Target Acquisition Appili Therapeutics Announces..
06/11/202423:55GLOBEAppili Therapeutics Announces Results of Special Meeting of..
06/11/202414:30BWAditxt Acquisition Target Evofem Biosciences Secures..
06/11/202414:00PRNUSEvofem Secures Investor Support for Proposed Merger through..
05/11/202422:15EDGAR2Form 8-K - Current report
31/10/202418:00APSBiopharma Bucking Market Trends on Positive FDA Feedback
31/10/202413:30BWAditxt’s Target Acquisition Appili Therapeutics Announces..
31/10/202412:15GLOBEAppili Therapeutics Announces Alignment with FDA on..
30/10/202422:00BWAditxt To Host Virtual Stakeholder Update and Q&A Session on..
30/10/202421:15EDGAR2Form 8-K - Current report
29/10/202421:42EDGAR2Form 8-K - Current report
29/10/202413:15BWSylvia Hermina Joins Aditxt’s Board of Directors, Elevating..
28/10/202413:15BWAditxt Completes Final Equity Investment and Key Milestone..
25/10/202422:15EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
21/10/202414:15BWAditxt to Host a Virtual Fireside Chat with Aditxt CEO Amro..
11/10/202423:11EDGAR2Form 8-K - Current report
10/10/202414:15BWAditxt’s Acquisition Target Appili Therapeutics Will Hold a..
09/10/202422:15EDGAR2Form 8-K - Current report
09/10/202416:52BWAditxt To Host Stakeholder Update and Q&A Session on Friday,..
08/10/202414:15BWAditxt Completes Third Parent Equity Investment Under..
07/10/202415:23EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
07/10/202414:54EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
03/10/202422:30EDGAR2Form 8-K - Current report
03/10/202414:15BWAditxt Delivers Shareholder Update and 2024 Year-End Plan
27/9/202414:15BWAditxt, Inc. (NASDAQ: ADTX) Announces 1-for-40 Reverse Stock..
24/9/202414:15BWEvofem Biosciences Files Preliminary Proxy for Stockholder..
23/9/202423:23EDGAR2Form 8-K - Current report
20/9/202414:15BWAditxt’s Subsidiary Pearsanta to Collaborate with Evofem..
16/9/202422:20EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
16/9/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
Apertura: Min: Max:
Chiusura: 0,056

La tua Cronologia

NASDAQ
ADTX
Aditxt
BIT
NSCIT0053917
Isaia E Isaia
BIT
NSCIT2228194
International Finance
BIT
S27876
Societe Generale Effekten
NASDAQ
JZ
Jianzhi Education Techno...
BIT
FCT
Fincantieri
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci